Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Acorda Therapeutics (ACOR)
Acorda Therapeutics (ACOR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,019
  • Shares Outstanding, K 24,338
  • Annual Sales, $ 118,570 K
  • Annual Income, $ -65,920 K
  • 60-Month Beta 1.43
  • Price/Sales 0.12
  • Price/Cash Flow N/A
  • Price/Book 0.16
Trade ACOR with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -4.71
  • Most Recent Earnings 0.57 on 03/09/23
  • Next Earnings Date 05/10/23
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 274.26% ( +274.26%)
  • Historical Volatility 95.42%
  • IV Percentile 69%
  • IV Rank 26.59%
  • IV High 952.87% on 07/06/22
  • IV Low 28.49% on 04/13/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 38
  • Put/Call OI Ratio 0.32
  • Today's Open Interest 1,515
  • Open Int (30-Day) 1,539

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.5255 +7.48%
on 03/24/23
1.0800 -47.70%
on 03/09/23
-0.3387 (-37.49%)
since 02/28/23
3-Month
0.5255 +7.48%
on 03/24/23
1.1800 -52.14%
on 01/19/23
-0.0602 (-9.63%)
since 12/28/22
52-Week
0.2611 +116.32%
on 09/29/22
1.7400 -67.54%
on 03/29/22
-1.1152 (-66.38%)
since 03/28/22

Most Recent Stories

More News
Acorda Therapeutics CEO Ron Cohen, M.D., to Hold Virtual Company Presentation and Q&A

Acorda Therapeutics, Inc. (Nasdaq: ACOR) will hold a virtual, video Q&A with its CEO, Ron Cohen, M.D., on Tuesday, April 4 at 1:00pm ET, 10:00am PT.

ACOR : 0.5800 (-2.76%)
Acorda: Q4 Earnings Snapshot

Acorda: Q4 Earnings Snapshot

ACOR : 0.5800 (-2.76%)
Acorda Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today reported its financial results for the fourth quarter and full year ended December 31, 2022.

ACOR : 0.5800 (-2.76%)
ESTEVE Launches INBRIJA® in Spain

Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Esteve Pharmaceuticals, S.A. has launched INBRIJA 33 mg (levodopa inhalation powder, hard capsules) in Spain. INBRIJA is indicated in the EU for...

ACOR : 0.5800 (-2.76%)
Acorda Fourth Quarter/Year End 2022 Update: Webcast/Conference Call Scheduled for March 9, 2023

Acorda Therapeutics, Inc. (Nasdaq: ACOR) will host a webcast/conference call in conjunction with its fourth quarter and year end 2022 update and financial results on Thursday, March 9 at 8:30 a.m. ET.

ACOR : 0.5800 (-2.76%)
Acorda Therapeutics Receives Nasdaq Extension to Meet Minimum Bid Price Requirement

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that the Nasdaq Hearings Panel has granted the Company’s extension request until June 20, 2023 to regain compliance with the Nasdaq's minimum...

ACOR : 0.5800 (-2.76%)
Acorda Therapeutics to Present at Sequire Biotechnology Conference

Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., Acorda’s President and Chief Executive Officer, will make a virtual presentation at the Sequire Biotechnology Conference on Thursday,...

ACOR : 0.5800 (-2.76%)
Acorda Therapeutics Announces New Agreement with Catalent for Long-Term Global Supply of INBRIJA®

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that on December 31, 2022 it entered into a new long-term global supply agreement with Catalent for the manufacture of INBRIJA (levodopa inhalation...

ACOR : 0.5800 (-2.76%)
Acorda Therapeutics Announces Revised Long-Term Financial Guidance

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it has revised and updated the long-term financial guidance most recently included in its November 1, 2022 press release announcing its financial...

ACOR : 0.5800 (-2.76%)
Acorda Therapeutics Receives Nasdaq Listing Determination Letter and Plans to Request a Hearing

Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it was notified by the Listing Qualifications Staff of The Nasdaq Stock Market LLC that, due to the Company's common stock not having regained...

ACOR : 0.5800 (-2.76%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Acorda Therapeutics, Inc. is a biotechnology company developing and commercializing neurology therapies for Parkinson's disease, migraine and multiple sclerosis. Acorda has a pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease and multiple sclerosis....

See More

Key Turning Points

3rd Resistance Point 0.6898
2nd Resistance Point 0.6539
1st Resistance Point 0.6149
Last Price 0.5800
1st Support Level 0.5400
2nd Support Level 0.5041
3rd Support Level 0.4651

See More

52-Week High 1.7400
Fibonacci 61.8% 1.1751
Fibonacci 50% 1.0006
Fibonacci 38.2% 0.8260
Last Price 0.5800
52-Week Low 0.2611

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar